AN2 Therapeutics, Inc. Insider Trading
ANTX
Insiders bought 12K and sold 406K on the open market.
78% of the selling was scheduled in advance under 10b5-1 plans. See Remarks Joshua M Eizen sold 25K on Jan 6, 14% of their stake, outside a plan.
Get an email when ANTX's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 5 | Joshua M Eizen See Remarks | SoldNo plan | 2,826 | $4.22 | 12K | 1.3% | Form 4 |
| Sep 9 | Robin Shane Readnour Director | Sold10b5-1 plan 2 parts | 1,108 | $6.02 average | 7K | 0.2% | Form 4 |
| Sep 3 – 8 | Robin Shane Readnour Director | Sold10b5-1 plan 4 parts | 16,119 | $6.04 average | 97K | 2.5% | Form 4 |
| Sep 1 | Sarah Joanne Williams Principal Accounting Officer | SoldNo plan | 272 | $5.53 | 2K | 0.4% | Form 4 |
| Sep 1 | Margaret M Fitzpatrick Director | Bought | 2,098 | $5.53 | 12K | 24% | Form 4 |
| Aug 17 | Robin Shane Readnour Director | Sold10b5-1 plan 2 parts | 35,402 | $6.01 average | 213K | 5.2% | Form 4 |
| Jul 8 | Joshua M Eizen See Remarks | SoldNo plan | 5,945 | $4.17 | 25K | 2.8% | Form 4 |
| May 29 | Sarah Joanne Williams Principal Accounting Officer | SoldNo plan | 265 | $4.43 | 1K | 0.4% | Form 4 |
| Mar 3 | Sarah Joanne Williams Principal Accounting Officer | SoldNo plan | 327 | $1.06 | $347 | 0.5% | Form 4 |
| Jan 5 – 6 | Lucy Day Chief Financial Officer | SoldNo plan 2 parts | 8,807 | $1.01 average | 9K | 10% | Form 4 |
| Jan 5 – 6 | Stephen David Prior Chief Strategy Officer | SoldNo plan 2 parts | 6,462 | $1.00 average | 6K | 9.9% | Form 4 |
| Jan 5 – 6 | Sanjay Chanda Chief Development Officer | SoldNo plan 2 parts | 9,251 | $1.01 average | 9K | 11% | Form 4 |
| Jan 5 – 6 | Joshua M Eizen See Remarks | SoldNo plan 2 parts | 24,854 | $1.00 average | 25K | 14% | Form 4 |
| Nov 4, 2025 | Joshua M Eizen See Remarks | SoldNo plan | 2,819 | $1.14 | 3K | 1.6% | Form 4 |
| Nov 4, 2025 | Stephen David Prior Chief Strategy Officer | SoldNo plan | 765 | $1.14 | $872 | 1.2% | Form 4 |
| Jun 2, 2025 | Eric Easom Chief Executive Officer | Bought | 10,000 | $1.07 | 11K | 2.9% | Form 4 |
| May 28, 2025 – May 30, 2025 | Braden Michael Leonard Large holder | SoldNo plan 4 parts | 2,532,000 | $1.13 average | $2.87M | 44% | Form 4 |
| May 28, 2025 | Braden Michael Leonard Large holder | SoldNo plan | 200,000 | $1.09 | 218K | 6.2% | Form 4 |
| May 28, 2025 | Margaret M Fitzpatrick Director | Bought | 8,610 | $1.18 | 10K | New | Form 4 |
| Jan 3, 2025 | Lucy Day Chief Financial Officer | SoldNo plan | 2,957 | $1.34 | 4K | 8.3% | Form 4 |
| Jan 3, 2025 | Sanjay Chanda Chief Development Officer | SoldNo plan | 2,957 | $1.34 | 4K | 9.0% | Form 4 |
| Jan 3, 2025 | Stephen David Prior Chief Strategy Officer | SoldNo plan | 2,029 | $1.34 | 3K | 5.7% | Form 4 |
| Jan 3, 2025 | Joshua M Eizen See Remarks | SoldNo plan | 9,663 | $1.34 | 13K | 7.6% | Form 4 |
| Dec 6, 2024 – Dec 10, 2024 | Robin Shane Readnour Director | Bought 6 parts | 60,000 | $1.45 average | 87K | 10% | Form 4 |
| Nov 26, 2024 – Nov 27, 2024 | Robin Shane Readnour Director | Bought 4 parts | 75,000 | $1.41 average | 106K | 14% | Form 4 |
| Nov 27, 2024 | Joseph S Zakrzewski Director | Bought | 2,000 | $1.40 | 3K | 0.4% | Form 4 |
- Nov 5No planJoshua M EizenSee Remarks · sold 2,826 at $4.2212K1.3% of stake
- Sep 910b5-1 planRobin Shane ReadnourDirector · sold 1,108 at avg $6.027K0.2% of stake
- Sep 3 – 810b5-1 planRobin Shane ReadnourDirector · sold 16,119 at avg $6.0497K2.5% of stake
- Sep 1No planSarah Joanne WilliamsPrincipal Accounting Officer · sold 272 at $5.532K0.4% of stake
- Sep 1Margaret M FitzpatrickDirector · bought 2,098 at $5.5312K24% of stake
- Aug 1710b5-1 planRobin Shane ReadnourDirector · sold 35,402 at avg $6.01213K5.2% of stake
- Jul 8No planJoshua M EizenSee Remarks · sold 5,945 at $4.1725K2.8% of stake
- May 29No planSarah Joanne WilliamsPrincipal Accounting Officer · sold 265 at $4.431K0.4% of stake
- Mar 3No planSarah Joanne WilliamsPrincipal Accounting Officer · sold 327 at $1.06$3470.5% of stake
- Jan 5 – 6No planLucy DayChief Financial Officer · sold 8,807 at avg $1.019K10% of stake
- Jan 5 – 6No planStephen David PriorChief Strategy Officer · sold 6,462 at avg $1.006K9.9% of stake
- Jan 5 – 6No planSanjay ChandaChief Development Officer · sold 9,251 at avg $1.019K11% of stake
- Jan 5 – 6No planJoshua M EizenSee Remarks · sold 24,854 at avg $1.0025K14% of stake
- Nov 4, 2025No planJoshua M EizenSee Remarks · sold 2,819 at $1.143K1.6% of stake
- Nov 4, 2025No planStephen David PriorChief Strategy Officer · sold 765 at $1.14$8721.2% of stake
- Jun 2, 2025Eric EasomChief Executive Officer · bought 10,000 at $1.0711K2.9% of stake
- May 28, 2025 – May 30, 2025No planBraden Michael LeonardLarge holder · sold 2,532,000 at avg $1.13$2.87M44% of stake
- May 28, 2025No planBraden Michael LeonardLarge holder · sold 200,000 at $1.09218K6.2% of stake
- May 28, 2025Margaret M FitzpatrickDirector · bought 8,610 at $1.1810KNew position
- Jan 3, 2025No planLucy DayChief Financial Officer · sold 2,957 at $1.344K8.3% of stake
- Jan 3, 2025No planSanjay ChandaChief Development Officer · sold 2,957 at $1.344K9.0% of stake
- Jan 3, 2025No planStephen David PriorChief Strategy Officer · sold 2,029 at $1.343K5.7% of stake
- Jan 3, 2025No planJoshua M EizenSee Remarks · sold 9,663 at $1.3413K7.6% of stake
- Dec 6, 2024 – Dec 10, 2024Robin Shane ReadnourDirector · bought 60,000 at avg $1.4587K10% of stake
- Nov 26, 2024 – Nov 27, 2024Robin Shane ReadnourDirector · bought 75,000 at avg $1.41106K14% of stake
- Nov 27, 2024Joseph S ZakrzewskiDirector · bought 2,000 at $1.403K0.4% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with ANTX
Held by ETFs
ANTX is in 1 US ETF. The largest of them, with ANTX's weight in each:
Spot a number that looks wrong? Check it in ANTX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ANTX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.